FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jürg Nussberger

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Renin-Angiotensin System

Living Beings

Rats

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Jürg Nussberger; Jürgen Bohlender
Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
Jürgen Bohlender; Jürg Nussberger; Hans Imboden
Angiotensinergic innervation of the kidney: present knowledge and its significance.
Rudolf A de Boer; Geneviève Nguyen; Jürg Nussberger; Luis M Ruilope; Roland E Schmieder; Michel Azizi; Ah Jan Danser; Massimo Volpe
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jürg Nussberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jürg Nussberger; Jürgen Bohlender
Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
Nature reviews. Cardiology 2013;10(4):183-4.
2013: Jürgen Bohlender; Jürg Nussberger; Hans Imboden
Angiotensinergic innervation of the kidney: present knowledge and its significance.
Current hypertension reports 2013;15(1):10-6.
2012: Rudolf A de Boer; Geneviève Nguyen; Jürg Nussberger; Luis M Ruilope; Roland E Schmieder; Michel Azizi; Ah Jan Danser; Massimo Volpe
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2012;13(3):409-12.
2012: Jürgen Bohlender; Joël Ménard; Michael Bader; Jürg Nussberger
Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Journal of hypertension 2012;30(8):1597-605.
2012: Stephan C Schäfer; Caroline Wyss; Jürg Nussberger; Maxime Pellegrin; Jean-François Aubert; Daniel Hayoz; Hans-Anton Lehr; Lucia Mazzolai
Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension.
Hypertension research : official journal of the Japanese Society of Hypertension 2012;35(8):855-61.
2012: Michael Boschmann; Marion Dahlke; Alexander Hessel Jan Danser; Stefan Engeli; Jürg Nussberger; Margaret F Prescott; Ching-Ming Yeh; Jens Jordan
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients.
Journal of hypertension 2012;30(3):561-6.
2009: Maxime Pellegrin; Florian Alonso; Jean-François Aubert; Karima Bouzourene; Vincent Braunersreuther; François Mach; Jacques-Antoine Haefliger; Daniel Hayoz; Alain Berthelot; Jürg Nussberger; Pascal Laurant; Lucia Mazzolai
Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes.
Hypertension 2009;53(5):782-9.
2008: Jürg Nussberger; Jean-François Aubert; Karima Bouzourene; Maxime Pellegrin; Daniel Hayoz; Lucia Mazzolai
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Hypertension 2008;51(5):1306-11.
2008: Andreas J Flammer; Isabella Sudano; Frank Hermann; Steffen Gay; Adrian Forster; Michel Neidhart; Peter Künzler; Frank Enseleit; Daniel Périat; Matthias Hermann; Jürg Nussberger; Thomas F Luscher; Roberto Corti; Georg Noll; Frank Ruschitzka
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
Circulation 2008;117(17):2262-9.
2008: Alexander Hessel Jan Danser; Alan Charney; David L Feldman; Jürg Nussberger; Naomi Fisher; Norman Hollenberg
The renin rise with aliskiren: it's simply stoichiometry.
Hypertension 2008;51(4):e27-8; author reply e29.
2008: Alain C Tissot; Patrik Maurer; Jürg Nussberger; Robert Sabat; Thomas Pfister; Stanislav Ignatenko; Hans-Dieter Volk; Hans Stocker; Philipp Müller; Gary T Jennings; Frank Wagner; Martin F Bachmann
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
Lancet 2008;371(9615):821-7.
2007: Collette C Jonkam; Perenlei Enkhbaatar; Yoshimitsu Nakano; Thomas Boehm; Jianpu Wang; Jürg Nussberger; Aimalohi Esechie; Lillian D Traber; David Herndon; Daniel L Traber
Effects of the bradykinin B2 receptor antagonist icatibant on microvascular permeability after thermal injury in sheep.
Shock (Augusta, Ga.) 2007;28(6):704-9.
2007: Gabriella Garruti; Vittorio Giusti; Jürg Nussberger; Christian Darimont; Chantal Verdumo; Catherine Amstutz; Francesco Puglisi; Francesco Giorgino; Riccardo Giorgino; Susanna Cotecchia
Expression and secretion of the atrial natriuretic peptide in human adipose tissue and preadipocytes.
Obesity (Silver Spring, Md.) 2007;15(9):2181-9.
2007: Jürg Nussberger; Alan H Gradman; Roland E Schmieder; R L Lins; Yanntong Chiang; M F Prescott
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
International journal of clinical practice 2007;61(9):1461-8.
2007: Konrad Bork; Jorge Frank; Boris Grundt; Peter Schlattmann; Jürg Nussberger; Wolfhart Kreuz
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
The Journal of allergy and clinical immunology 2007;119(6):1497-503.
2007: Chin B Eap; Murielle Bochud; Robert C Elston; Pascal Bovet; Marc Maillard; Jürg Nussberger; Laurent Schild; Conrad Shamlaye; Michel Burnier
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Hypertension 2007;49(5):1007-14.
2007: Jürg Nussberger
[Blood pressure lowering tripeptides derived from milk protein].
Therapeutische Umschau. Revue thérapeutique 2007;64(3):177-9.
2007: Eoin O'Brien; John Barton; Jürg Nussberger; David Mulcahy; Chris Jensen; Patrick Dicker; Alice Stanton
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
Hypertension 2007;49(2):276-84.
2007: Patrice M Ambühl; Alain C Tissot; Alma Fulurija; Patrik Maurer; Jürg Nussberger; Robert Sabat; Vera Nief; Charlotte Schellekens; Katja Sladko; Kirsten Roubicek; Thomas Pfister; Manfred Rettenbacher; Hans-Dieter Volk; Frank Wagner; Philipp Müller; Gary T Jennings; Martin F Bachmann
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Journal of hypertension 2007;25(1):63-72.
2006: Anne Zanchi; Christine Perregaux; Marc Maillard; Daniel Cefai; Jürg Nussberger; Michel Burnier
The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
American journal of physiology. Endocrinology and metabolism 2006;291(6):E1228-34.
2006: Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Plasma aldosterone is independently associated with the metabolic syndrome.
Hypertension 2006;48(2):239-45.
2006: Lucia Mazzolai; Martine Korber; Karima Bouzourene; Jean-François Aubert; Jürg Nussberger; Ivan Stamenkovic; Daniel Hayoz
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Atherosclerosis 2006;186(1):86-91.
2006: Martin F Bachmann; Jürg Nussberger; Alain C Tissot; Gary T Jennings
Reply to 'Blood pressure vaccine shot down by safety concerns'.
Nature medicine 2006;12(3):270.
2006: Michel Azizi; Randy Webb; Jürg Nussberger; Norman K Hollenberg
Renin inhibition with aliskiren: where are we now, and where are we going?
Journal of hypertension 2006;24(2):243-56.
2005: Christopher Hasler; Jürg Nussberger; Marc Maillard; Andrei Forclaz; Hans R Brunner; Michel Burnier
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 2005;78(5):501-7.
2005: Grégoire Wuerzner; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Michel Burnier
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.
Kidney international 2005;68(2):688-94.
2005: Moritz Gröger; Diane Lebesgue; Didier Pruneau; Jane Relton; Seong-Woong Kim; Jürg Nussberger; Nikolaus Plesnila
Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2005;25(8):978-89.
2005: Massimo Cugno; Piergiuseppe Agostoni; Daniela Mari; Pier Luigi Meroni; Luisa Gregorini; Maurizio Bussotti; Gian Battista Anguissola; Francesco Donatelli; Jürg Nussberger
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
British journal of haematology 2005;130(1):113-20.
2005: Anette Fiebeler; Jürg Nussberger; Erdenechimeg Shagdarsuren; Song Rong; Georg Hilfenhaus; Nidal al-Saadi; Ralf Dechend; Maren Wellner; Silke Meiners; Christiane Maser-Gluth; Arco Y Jeng; Randy L Webb; Friedrich C Luft; Dominik N Muller
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Circulation 2005;111(23):3087-94.
2005: Alan H Gradman; Roland E Schmieder; Robert L Lins; Jürg Nussberger; Yanntong Chiang; Martin P Bedigian
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
Circulation 2005;111(8):1012-8.
2004: Noureddine Brakch; Saad Abdel-Sayed; Flore Allemandou; Qing Wang; Jean-François Aubert; Hans R Brunner; Jürg Nussberger
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Journal of hypertension 2004;22(9):1797-803.
2004: Lucia Mazzolai; Michel A Duchosal; Martine Korber; Karima Bouzourene; Jean-François Aubert; Hiroyuki Hao; Véronique Vallet; Hans R Brunner; Jürg Nussberger; Giulio Gabbiani; Daniel Hayoz
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Hypertension 2004;44(3):277-82.
2004: Anne Zanchi; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
The Journal of clinical endocrinology and metabolism 2004;89(3):1140-5.
2004: Ferrari Paolo; Sidney G Shaw; Jérôme Nicod; Esther Saner; Jürg Nussberger
Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Journal of hypertension 2004;22(2):377-81.
2004: Jürg Nussberger; Hiroyuki Koike
Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.
Clinical therapeutics 2004;26 Suppl A():A12-20.
2004: Grégoire Wuerzner; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier; Arnaud Chiclero
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Kidney international 2004;65(1):238-44.
2003: Saad Abdel-Sayed; Hans R Brunner; Jürg Nussberger
Volume expansion enhances plasma endothelin-1.
American journal of hypertension 2003;16(12):1057-61.
2003: Alice Stanton; Chris Jensen; Jürg Nussberger; Eoin O'Brien
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.
Hypertension 2003;42(6):1137-43.
2003: Noureddine Brakch; Jürg Nussberger
Blood pressure regulation in low renin subjects.
Journal of hypertension 2003;21(10):1821-2.
2003: Saad Abdel-Sayed; Jürg Nussberger; Jean-François Aubert; Peter Gohlke; Hans R Brunner; Noureddine Brakch
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects.
American journal of hypertension 2003;16(7):515-21.
2003: Jürg Nussberger
Investigating mineralocorticoid hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S25-30.
2003: Massimo Cugno; Jürg Nussberger; Marco Cicardi; Angelo Agostoni
Bradykinin and the pathophysiology of angioedema.
International immunopharmacology 2003;3(3):311-7.
2003: Andrei Forclaz; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension 2003;41(1):31-6.
2002: Frédéric Regamey; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Hypertension 2002;40(3):266-72.
2002: Jürg Nussberger; Massimo Cugno; Marco Cicardi
Bradykinin-mediated angioedema.
The New England journal of medicine 2002;347(8):621-2.
2002: Qing Wang; Edith Hummler; Jürg Nussberger; Sophie Clément; Giulio Gabbiani; Hans R Brunner; Michel Burnier
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Journal of the American Society of Nephrology : JASN 2002;13(6):1509-16.
2002: Marc Maillard; Grégoire Würzner; Jürg Nussberger; Catherine Centeno; Michel Burnier; Hans R Brunner
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Clinical pharmacology and therapeutics 2002;71(1):68-76.
2002: Jürg Nussberger; Grégoire Wuerzner; Chris Jensen; Hans R Brunner
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Hypertension 2002;39(1):E1-8.
2001: Corinne Pellieux; Alessandro Foletti; G Peduto; Jean-François Aubert; Jürg Nussberger; Friedrich Beermann; Hans R Brunner; Thierry Pedrazzini
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
The Journal of clinical investigation 2001;108(12):1843-51.
2001: Massimo Cugno; Jürg Nussberger; P Biglioli; F Alamanni; R Coppola; Angelo Agostoni
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.
Chest 2001;120(6):1776-82.
2001: Massimo Cugno; Francesco Salerno; Jürg Nussberger; Bianca Bottasso; Elettra Lorenzano; Angelo Agostoni
Bradykinin in the ascitic fluid of patients with liver cirrhosis.
Clinical science (London, England : 1979) 2001;101(6):651-7.
2001: Grégoire Würzner; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; D Hayoz; Hans R Brunner; Michel Burnier
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Kidney international 2001;60(4):1469-76.
2001: Hans R Brunner; Jürg Nussberger
Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(1):S15-20.
2001: Qing Wang; Edith Hummler; Marc Maillard; Jürg Nussberger; Bernard C Rossier; Hans R Brunner; Michel Burnier
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Kidney international 2001;59(6):2216-21.
2001: Jürg Nussberger; D B Brunner; J A Nyfeler; L Linder; H R Brunner
Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood.
Clinical chemistry 2001;47(4):726-9.
2000: Michel Burnier; M L Monod; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Journal of hypertension 2000;18(11):1657-64.
2000: Massimo Cugno; Piergiuseppe Agostoni; H R Brunner; Marco Gardinali; Angelo Agostoni; Jürg Nussberger
Plasma bradykinin levels in human chronic congestive heart failure.
Clinical science (London, England : 1979) 2000;99(5):461-6.
2000: Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Hypertension 2000;36(4):631-7.
2000: Lucia Mazzolai; Thierry Pedrazzini; F Nicoud; Giulio Gabbiani; Hans R Brunner; Jürg Nussberger
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Hypertension 2000;35(4):985-91.
2000: Marc Maillard; J Rossat; Jürg Nussberger; J Ramis; Caridad Pontes; Michel Burnier; Hans R Brunner
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Journal of cardiovascular pharmacology 2000;35(3):383-9.
2000: P Rousso; Thierry Buclin; Jürg Nussberger; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
European journal of clinical pharmacology 2000;55(10):749-54.
1999: Marc Maillard; Lucia Mazzolai; V Daven; Catherine Centeno; Jürg Nussberger; Hans R Brunner; Michel Burnier
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
American journal of hypertension 1999;12(12 Pt 1-2):1201-8.
1999: Jürg Nussberger; Massimo Cugno; Marco Cicardi; Angelo Agostoni
Local bradykinin generation in hereditary angioedema.
The Journal of allergy and clinical immunology 1999;104(6):1321-2.
1999: Michel Burnier; A F Fricker; D Hayoz; Jürg Nussberger; Hans R Brunner
Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects.
European journal of clinical pharmacology 1999;55(9):633-7.
1999: Angelo Agostoni; Marco Cicardi; Massimo Cugno; Lorenza C Zingale; D Gioffré; Jürg Nussberger
Angioedema due to angiotensin-converting enzyme inhibitors.
Immunopharmacology 1999;44(1-2):21-5.
1999: Massimo Cugno; Jürg Nussberger; P Biglioli; M G Giovagnoni; Marco Gardinali; Angelo Agostoni
Cardiopulmonary bypass increases plasma bradykinin concentrations.
Immunopharmacology 1999;43(2-3):145-7.
1999: J Rossat; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Clinical pharmacology and therapeutics 1999;66(1):76-84.
1999: P Rousso; Thierry Buclin; Jürg Nussberger; Laurent A Décosterd; S D La Roche; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Journal of hypertension 1999;17(3):427-37.
1999: Lucia Mazzolai; Marc Maillard; J Rossat; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Hypertension 1999;33(3):850-5.
1999: A Pechère-Bertschi; Jürg Nussberger; Michel Burnier
[Does constitutional hypotension exist?].
Therapeutische Umschau. Revue thérapeutique 1999;56(1):49-54.
1998: A F Fricker; Jürg Nussberger; S Meilenbrock; Hans R Brunner; Michel Burnier
Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
Kidney international 1998;54(6):2089-97.
1998: A Pechère-Bertschi; Jürg Nussberger; Jérôme Biollaz; M Fahti; E Grouzmann; T Morgan; Hans R Brunner; Michel Burnier
Circadian variations of renal sodium handling in patients with orthostatic hypotension.
Kidney international 1998;54(4):1276-82.
1998: Jürg Nussberger; Massimo Cugno; C Amstutz; Marco Cicardi; A Pellacani; Angelo Agostoni
Plasma bradykinin in angio-oedema.
Lancet 1998;351(9117):1693-7.
1998: Lucia Mazzolai; Jürg Nussberger; Jean-François Aubert; D B Brunner; Giulio Gabbiani; Hans R Brunner; Thierry Pedrazzini
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Hypertension 1998;31(6):1324-30.
1998: A Pechère-Bertschi; Jürg Nussberger; L Decosterd; C Armagnac; J Sissmann; M Bouroudian; Hans R Brunner; Michel Burnier
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Journal of hypertension 1998;16(3):385-93.
1998: P Rousso; Thierry Buclin; Jürg Nussberger; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
Journal of cardiovascular pharmacology 1998;31(3):408-17.
1997: M Hagmann; Jürg Nussberger; R B Naudin; T S Burns; A Karim; Bernard Waeber; Hans R Brunner
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
Journal of cardiovascular pharmacology 1997;29(4):444-50.
1997: P Wiesel; Lucia Mazzolai; Jürg Nussberger; Thierry Pedrazzini
Two-kidney, one clip and one-kidney, one clip hypertension in mice.
Hypertension 1997;29(4):1025-30.
1996: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Experience with angiotensin II antagonists in hypertensive patients.
Clinical and experimental pharmacology & physiology 1996;23 Suppl 3():S142-6.
1996: B Noël; G Del Re; P Capone; Hans R Brunner; Jürg Nussberger
Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081.
Journal of cardiovascular pharmacology 1996;28(2):252-8.
1996: D Evéquoz; Jean-François Aubert; Jürg Nussberger; Jérôme Biollaz; J Diezi; Hans R Brunner; Bernard Waeber
Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.
Nephron 1996;73(3):467-72.
1995: Jacques-Antoine Haefliger; G Bergonzelli; Gérard Waeber; Jean-François Aubert; Jürg Nussberger; H Gavras; Pascal Nicod; Bernard Waeber
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats.
Hypertension 1995;26(5):733-7.
1995: D Evéquoz; Eric Grouzmann; Jürg Nussberger; M Niederberger; Hans R Brunner; Bernard Waeber
Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats.
Regulatory peptides 1995;58(3):163-6.
1995: E Delacrétaz; Anne Zanchi; Jürg Nussberger; Daniel Hayoz; Jean-François Aubert; Hans R Brunner; Bernard Waeber
Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Hypertension 1995;26(2):332-6.
1995: M Burnier; A Pechère-Bertschi; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):108-15.
1995: B Favrat; M Burnier; Jürg Nussberger; J M Lecomte; R Brouard; Bernard Waeber; Hans R Brunner
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Journal of hypertension 1995;13(7):797-804.
1995: N Inglessis; Jürg Nussberger; M Hagmann; O Hiesse-Provost; J Insuasty; J Reid; J Ménard; Hans R Brunner
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Journal of cardiovascular pharmacology 1995;25(6):986-93.
1995: Anne Zanchi; N C Schaad; M C Osterheld; E Grouzmann; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
The American journal of physiology 1995;268(6 Pt 2):H2267-73.
1995: M Burnier; M Hagman; Jürg Nussberger; J Biollaz; C Armagnac; R Brouard; B Weber; Hans R Brunner
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Hypertension 1995;25(4 Pt 1):602-9.
1995: M Niederberger; Jean-François Aubert; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Journal of hypertension 1995;13(4):439-45.
1995: E Delacrétaz; Jürg Nussberger; J Biollaz; Bernard Waeber; Hans R Brunner
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
Hypertension 1995;25(1):14-21.
1994: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Dose-response relationships of ACE inhibitors and angiotensin II blockers.
European heart journal 1994;15 Suppl D():123-8.
1994: Jürg Nussberger; E Fleck; H Bahrmann; W Delius; Heinz-Peter Schultheiss; Hans R Brunner
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
European heart journal 1994;15 Suppl D():113-22.
1994: Hans R Brunner; E Delacrétaz; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists DuP 753 and TCV 116.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(9):S29-34.
1994: A Pellacani; Hans R Brunner; Jürg Nussberger
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Clinical science (London, England : 1979) 1994;87(5):567-74.
1994: E Delacrétaz; Jürg Nussberger; K Püchler; A J Wood; P R Robinson; Bernard Waeber; Hans R Brunner
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
Journal of cardiovascular pharmacology 1994;24(3):479-85.
1994: Anne Zanchi; Jürg Nussberger; M Criscuoli; P Capone; Hans R Brunner
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
Journal of cardiovascular pharmacology 1994;24(2):317-22.
1994: R M Zusman; K Y Hui; Jürg Nussberger; D M Christensen; J Higgins; W D Carlson; D Schoenfeld; E Haber
R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers.
American journal of hypertension 1994;7(4 Pt 1):295-301.
1994: D Evequoz; Michel Burnier; M Niederberger; Hans R Brunner; Jürg Nussberger; Bernard Waeber
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Clinical and experimental pharmacology & physiology 1994;21(2):93-100.
1993: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Control of vascular tone by renin and angiotensin in cardiovascular disease.
European heart journal 1993;14 Suppl I():149-53.
1993: Hans R Brunner; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(6):1221-38.
1993: Michel Burnier; B Rutschmann; Jürg Nussberger; J Versaggi; S Shahinfar; Bernard Waeber; Hans R Brunner
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Hypertension 1993;22(3):339-47.
1993: M Porchet; Jürg Nussberger; Hans R Brunner; Bernard Waeber
[Blood pressure recording in outpatient service: experience with the Sandoz Pressure System].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(11):320-2.
1993: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Angiotensin antagonists.
Advances in nephrology from the Necker Hospital 1993;22():305-27.
1993: D Hayoz; Jürg Nussberger; Bernard Waeber; Hans R Brunner
The renin-angiotensin system and arterial wall behavior.
Journal of cardiovascular pharmacology 1993;22 Suppl 5():S48-52.
1992: Hans R Brunner; Bernard Waeber; Jürg Nussberger
Strategies for the management of hypertension in aircrew.
European heart journal 1992;13 Suppl H():45-9.
1992: Hans R Brunner; Y Christen; Alain Munafo; R J Lee; Bernard Waeber; Jürg Nussberger
Clinical experience with angiotensin II receptor antagonists.
American journal of hypertension 1992;5(12 Pt 2):243S-246S.
1992: Daniel Hayoz; B Rutschmann; F Perret; M Niederberger; Yanik Tardy; V Mooser; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Conduit artery compliance and distensibility are not necessarily reduced in hypertension.
Hypertension 1992;20(1):1-6.
1992: Jürg Nussberger; D Brunner; I Keller; Hans R Brunner
Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
American journal of hypertension 1992;5(6 Pt 1):393-8.
1992: Alain Munafo; Y Christen; Jürg Nussberger; L Y Shum; R M Borland; R J Lee; Bernard Waeber; J Biollaz; Hans R Brunner
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Clinical pharmacology and therapeutics 1992;51(5):513-21.
1992: M Ganslmayer; F Perret; Bernard Waeber; Jürg Nussberger; Hans R Brunner
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder].
Schweizerische medizinische Wochenschrift 1992;122(15):544-8.
1992: Jean-François Aubert; P Walker; E Grouzmann; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats.
Clinical and experimental pharmacology & physiology 1992;19(4):223-8.
1992: A Pellacani; Hans R Brunner; Jürg Nussberger
Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S28-34.
1991: M Niederberger; Daniel Hayoz; B Rutschmann; Yanik Tardy; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Neither hydralazine nor captopril significantly shifts carotid artery distensibility-pressure curves determined in intact spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S404-5.
1991: Jürg Nussberger; J P Flückiger; K Y Hui; D Evéquoz; Bernard Waeber; Hans R Brunner
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S230-1.
1991: Bernard Waeber; M Niederberger; Jürg Nussberger; Hans R Brunner
Ambulatory blood pressure monitoring in children, adolescents and elderly people.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(8):S72-4.
1991: F Perret; V Mooser; Daniel Hayoz; Yanik Tardy; Jean-Jacques Meister; J D Etienne; P A Farine; A Marazzi; Michel Burnier; Jürg Nussberger
Evaluation of arterial compliance-pressure curves. Effect of antihypertensive drugs.
Hypertension 1991;18(4 Suppl):II77-83.
1991: E Camenzind; Jürg Nussberger; L Juillerat; Alain Munafo; W Fischli; Philippe Coassolo; P van Brummelen; C H Kleinbloesem; Bernard Waeber; Hans R Brunner
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Journal of cardiovascular pharmacology 1991;18(3):299-307.
1991: Michel Burnier; M Ganslmayer; F Perret; M Porchet; T Kosoglou; A Gould; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):181-91.
1991: D Evéquoz; T Reichenstein; Bernard Waeber; Jürg Nussberger; Hans R Brunner
[ACE inhibitors in the treatment of hypertension in elderly patients].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1991;80(25):701-6.
1991: Y Christen; Bernard Waeber; Jürg Nussberger; M Porchet; R M Borland; R J Lee; K Maggon; L Shum; P B Timmermans; Hans R Brunner
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
Circulation 1991;83(4):1333-42.
1991: Y Christen; Bernard Waeber; Jürg Nussberger; R J Lee; P B Timmermans; Hans R Brunner
Dose-response relationships following oral administration of DuP 753 to normal humans.
American journal of hypertension 1991;4(4 Pt 2):350S-353S.
1991: Urs Scherrer; Jürg Nussberger; S Torriani; Bernard Waeber; R Darioli; J R Hofstetter; Hans R Brunner
Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium.
Circulation 1991;83(2):552-8.
1990: S Vonmoos; Jürg Nussberger; Bernard Waeber; Jérôme Biollaz; Hans R Brunner; P Leuenberger
Effect of metoclopramide on angiotensins, aldosterone, and atrial peptide during hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;69(6):2072-7.
1990: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S149-53.
1990: Y Christen; M Ganslmayer; Bernard Waeber; M Burnier; Jürg Nussberger; Hans R Brunner
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(6):S119-24.
1990: L Juillerat; Jürg Nussberger; J Ménard; V Mooser; Y Christen; Bernard Waeber; P Graf; Hans R Brunner
Determinants of angiotensin II generation during converting enzyme inhibition.
Hypertension 1990;16(5):564-72.
1990: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S37-41.
1990: Y Christen; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in man.
Journal of clinical pharmacology 1990;30(8):711-4.
1990: Jürg Nussberger; V Mooser; G Maridor; L Juillerat; Bernard Waeber; Hans R Brunner
Caffeine-induced diuresis and atrial natriuretic peptides.
Journal of cardiovascular pharmacology 1990;15(5):685-91.
1990: V Mooser; Jürg Nussberger; L Juillerat; Michel Burnier; Bernard Waeber; J Bidiville; N Pauly; Hans R Brunner
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Journal of cardiovascular pharmacology 1990;15(2):276-82.
1990: Bernard Waeber; Jürg Nussberger; Hans R Brunner
[Angiotensin-converting-enzyme inhibition in arterial hypertension].
Wiener medizinische Wochenschrift (1946) 1990;140(1-2):22-30.
1990: Anne-Laure Lattion; J P Flückiger; Bernard Waeber; Jürg Nussberger; Jean-François Aubert; Hans R Brunner
Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.
Experientia 1990;46(1):69-72.
1990: Bernard Waeber; D Evéquoz; Jean-François Aubert; J P Flückiger; L Juillerat; Jürg Nussberger; Hans R Brunner
Prevention of renal hypertension in the rat by neuropeptide Y.
Journal of hypertension 1990;8(1):21-5.
1990: Bernard Waeber; Jürg Nussberger; Eric Grouzmann; Michel Burnier; Hans R Brunner
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):667-72.
1990: J P Flückiger; R Deghenghi; Bernard Waeber; H U Immer; Jürg Nussberger; Hans R Brunner
Effects of dextronatrin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats.
Fundamental & clinical pharmacology 1990;4(2):129-39.
1990: Bernard Waeber; M Niederberger; H Gavras; Jürg Nussberger; Hans R Brunner
Hemodynamic effects of a kinin antagonist.
Journal of cardiovascular pharmacology 1990;15 Suppl 6():S78-82.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S27-31.
1989: F Perret; V Mooser; Bernard Waeber; T Yanik; M Jean-Jacques; E Mooser; Jürg Nussberger; Hans R Brunner
Effect of cold pressor test on the internal diameter of the radial artery.
American journal of hypertension 1989;2(9):727-8.
1989: J P Flückiger; G Gremaud; Bernard Waeber; A Kulik; A Ichino; Jürg Nussberger; Hans R Brunner
Measurement of sympathetic nerve activity in the unanesthetized rat.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;67(1):250-5.
1989: Jürg Nussberger; A Delabays; M De Gasparo; F Cumin; Bernard Waeber; Hans R Brunner; J Ménard
Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Hypertension 1989;13(6 Pt 2):948-53.
1989: A Delabays; Jürg Nussberger; M Porchet; Bernard Waeber; P Hoyos; R Boger; H Glassman; H D Kleinert; R Luther; Hans R Brunner
Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Hypertension 1989;13(6 Pt 2):941-7.
1989: Bernard Waeber; Michel Burnier; F Perret; Jürg Nussberger; Hans R Brunner
Ambulatory blood pressure measurement and antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S33-9.
1989: M de Gasparo; F Cumin; Jürg Nussberger; T T Guyenne; J M Wood; J Menard
Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
British journal of clinical pharmacology 1989;27(5):587-96.
1989: Bernard Waeber; Jürg Nussberger; L Perret; J P Santoni; Hans R Brunner
Experience with perindopril in normal volunteers.
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 1():35-41.
1989: Michel Burnier; V Mooser; J P Wauters; H K Marder; P De Vane; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Journal of cardiovascular pharmacology 1989;13(5):682-90.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Angiotensin converting enzyme inhibition and renin inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(2):S75-9.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
American journal of hypertension 1989;2(4):286-93.
1989: V Mooser; Michel Burnier; Jürg Nussberger; L Juillerat; Bernard Waeber; Hans R Brunner
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Journal of hypertension 1989;7(3):211-6.
1989: Jürg Nussberger; L Juillerat; F Perret; Bernard Waeber; M Bellet; J Brunner; J Ménard
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
American heart journal 1989;117(3):717-22.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Pharmacokinetics of angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;28 Suppl 2():133S-139S; discussion 140S.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Clinical pharmacology of ACE inhibition.
Cardiology 1989;76 Suppl 2():11-22.
1989: Bernard Waeber; L Juillerat-Jeanneret; Jean-François Aubert; M Schapira; Jürg Nussberger; Hans R Brunner
Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;27 Suppl 2():175S-180S.
1989: Bernard Waeber; Jürg Nussberger; L Perret; J P Santoni; Hans R Brunner
Experience with perindopril in normal volunteers.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11 Suppl 2():507-19.
1989: P Y Erard; J P Gardaz; Jürg Nussberger; J J Livio; Bernard Waeber; Hans R Brunner; J Freeman
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia].
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R198.
1989: Gérard Waeber; M Burnier; M Porchet; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
European journal of clinical pharmacology 1989;36(6):587-91.
1989: Michel Burnier; V Mooser; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
British journal of clinical pharmacology 1989;27 Suppl 2():189S-197S.
1989: Bernard Waeber; Jürg Nussberger; L Juillerat; Hans R Brunner
Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S53-9.
1989: A Delabays; M Porchet; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers.
Journal of cardiovascular pharmacology 1989;13(1):173-6.
1988: Jürg Nussberger; I Keller; Bernard Waeber; Hans R Brunner
Angiotensin II measurement with high-affinity monoclonal antibodies.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S424-5.
1988: V Mooser; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Antihypertensive effect of diltiazem administered once and twice daily.
Journal of human hypertension 1988;2(4):257-60.
1988: Hans R Brunner; Bernard Waeber; Jürg Nussberger
What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(3):S1-5.
1988: Albert Mimran; Jürg Nussberger; Jean Ribstein; Bernard Waeber; Hans R Brunner
Response of atrial natriuretic peptide to acute saline loading in essential hypertension.
The American journal of physiology 1988;255(6 Pt 2):F1085-90.
1988: Gérard Waeber; Marc Schapira; Bernard Waeber; Jean-François Aubert; Jürg Nussberger; Hans R Brunner
Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
Circulatory shock 1988;26(4):375-82.
1988: S Torriani; Bernard Waeber; A Petrillo; R Di Stefano; V Mooser; Urs Scherrer; Jürg Nussberger; J R Hofstetter; Hans R Brunner
Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(1):S25-7.
1988: Bernard Waeber; Jean-François Aubert; J P Flückiger; Jürg Nussberger; R J Vavrek; J M Stewart; Hans R Brunner
Role of endogenous bradykinin in blood pressure control of conscious rats.
Kidney international. Supplement 1988;26():S63-8.
1988: Hans R Brunner; Bernard Waeber; Jürg Nussberger
Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
Kidney international. Supplement 1988;26():S80-5.
1988: Jean-François Aubert; Bernard Waeber; Bernard C Rossier; Käthi Geering; Jürg Nussberger; Hans R Brunner
Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
The Journal of pharmacology and experimental therapeutics 1988;246(3):1088-92.
1988: A Petrillo; Urs Scherrer; J J Gonvers; Jürg Nussberger; H Marder; P de Vane; Bernard Waeber; J R Hofstetter; Hans R Brunner
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Journal of cardiovascular pharmacology 1988;12(3):279-85.
1988: Anne-Laure Lattion; Jean-François Aubert; J P Flückiger; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effect of sodium intake on gene expression and plasma levels of ANF in rats.
The American journal of physiology 1988;255(2 Pt 2):H245-9.
1988: R Corder; Bernard Waeber; D Evequoz; Jürg Nussberger; R Gaillard; H Brunner
Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats.
Journal of cardiovascular pharmacology 1988;12(2):140-3.
1988: Bernard Waeber; Jean-François Aubert; R Corder; D Evéquoz; Jürg Nussberger; R Gaillard; Hans R Brunner
Cardiovascular effects of neuropeptide Y.
American journal of hypertension 1988;1(2):193-9.
1988: Gérard Waeber; G Beck; Bernard Waeber; J Bidiville; Jürg Nussberger; Hans R Brunner
Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Journal of hypertension 1988;6(3):239-45.
1988: Michel Burnier; Bernard Waeber; Jean-François Aubert; Jürg Nussberger; Hans R Brunner
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
The American journal of physiology 1988;254(3 Pt 2):H509-16.
1988: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; D J Dipette; J F Burris; Hans R Brunner
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
The Journal of pharmacology and experimental therapeutics 1988;244(3):1109-15.
1988: J Bidiville; Jürg Nussberger; Gérard Waeber; M Porchet; Bernard Waeber; Hans R Brunner
Individual responses to converting enzyme inhibitors and calcium antagonists.
Hypertension 1988;11(2):166-73.
1988: D Evéquoz; Bernard Waeber; Jean-François Aubert; J P Flückiger; Jürg Nussberger; Hans R Brunner
Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy.
Circulation research 1988;62(1):25-30.
1988: J Bidiville; Gérard Waeber; M Porchet; Jürg Nussberger; J Biollaz; H Gomez; L Callahan; Bernard Waeber; Hans R Brunner
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Fundamental & clinical pharmacology 1988;2(5):413-29.
1988: Jürg Nussberger; D B Brunner; Bernard Waeber; Hans R Brunner
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Life sciences 1988;42(17):1683-8.
1988: E Burgener; V Mooser; Bernard Waeber; M Porchet; J P Gardaz; Jürg Nussberger; Hans R Brunner
Calcium entry blockade attenuates the acute blood pressure rise induced by cigarette smoking.
Journal of cardiovascular pharmacology 1988;12 Suppl 6():S126-30.
1988: Jean-Jacques Goy; Bernard Waeber; Jürg Nussberger; J Bidiville; Jérôme Biollaz; P Nicod; V Mooser; Lukas Kappenberger; Hans R Brunner
Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Journal of cardiovascular pharmacology 1988;12(5):562-70.
1988: J P Flückiger; Bernard Waeber; A Mimran; Jürg Nussberger; W K Wahba; Hans R Brunner
Enhanced urinary kallikrein excretion in response to a moderate sodium load in genetically hypertensive rats.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S36-42.
1988: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist.
Journal of cardiovascular pharmacology 1988;11(1):51-5.
1987: D Evéquoz; Bernard Waeber; R Corder; Jürg Nussberger; R Gaillard; Hans R Brunner
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y.
Life sciences 1987;41(23):2573-80.
1987: D Evéquoz; Bernard Waeber; G Matsueda; Jürg Nussberger; Hans R Brunner
Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy.
European journal of pharmacology 1987;144(2):217-21.
1987: V Mooser; Gérard Waeber; J Bidiville; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Journal of clinical hypertension 1987;3(4):510-3.
1987: M D Schaller; Jürg Nussberger; François Feihl; Bernard Waeber; Hans R Brunner; C Perret; P Nicod
Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction.
The American journal of cardiology 1987;60(14):1178-80.
1987: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):681-5.
1987: Jérôme Biollaz; J Bidiville; J Diézi; Bernard Waeber; Jürg Nussberger; F Brunner-Ferber; H J Gomez; Hans R Brunner
Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
Kidney international 1987;32(4):537-46.
1987: Bernard Waeber; Urs Scherrer; A Petrillo; J Bidiville; Jürg Nussberger; Gérard Waeber; J R Hofstetter; Hans R Brunner
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording.
Lancet 1987;2(8561):732-4.
1987: Bernard Waeber; R Corder; Jean-François Aubert; Jürg Nussberger; R Gaillard; Hans R Brunner
Influence of sodium intake on circulating levels of neuropeptide Y.
Life sciences 1987;41(11):1391-6.
1987: Bernard Waeber; Jean-François Aubert; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakes.
Clinical and experimental pharmacology & physiology 1987;14(8):659-64.
1987: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
[Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin].
Archives des maladies du coeur et des vaisseaux 1987;80(6):832-4.
1987: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
Agents and actions. Supplements 1987;22():349-54.
1987: Hans R Brunner; J Bidiville; Gérard Waeber; M Porchet; Jürg Nussberger; Bernard Waeber
Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Nephron 1987;47 Suppl 1():87-9.
1987: Jürg Nussberger; M de Gasparo; L Juillerat; T T Guyenne; V Mooser; Bernard Waeber; Hans R Brunner
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1353-66.
1987: Hans R Brunner; Jürg Nussberger; J Bidiville; Gérard Waeber; M Porchet; Bernard Waeber
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.
Journal of cardiovascular pharmacology 1987;10 Suppl 10():S87-9.
1987: U Kaufmann; Marc Schapira; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
Circulatory shock 1987;23(3):215-23.